(Q37378113)

20 August 2017

1 reference

title

Mechanisms of antiphospholipid-induced thrombosis: effects on the protein C system (English)

1 reference

20 August 2017

0 references

Denis Wahl

1

1 reference

20 August 2017

Aurélie Membre

2

1 reference

20 August 2017

Christine Perret-Guillaume

3

1 reference

20 August 2017

Véronique Regnault

4

1 reference

20 August 2017

Thomas Lecompte

5

1 reference

20 August 2017

publication date

1 February 2009

1 reference

Current Rheumatology Reports

20 August 2017

published in

1 reference

20 August 2017

volume

11

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

77-81

1 reference

Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells

20 August 2017

cites work

1 reference

12 December 2020

Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants

1 reference

12 December 2020

Antibodies against phospholipids and beta 2-glycoprotein I increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus

1 reference

12 December 2020

Invitation to a debate on the serological criteria that define the antiphospholipid syndrome

1 reference

12 December 2020

Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Activated protein C resistance phenotype in patients with antiphospholipid antibodies

1 reference

12 December 2020

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis

1 reference

12 December 2020

Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies

1 reference

12 December 2020

Thrombin generation assays: accruing clinical relevance.

1 reference

12 December 2020

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

1 reference

12 December 2020

Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.

1 reference

12 December 2020

Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces

1 reference

12 December 2020

The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Antiphospholipid antibodies and the protein C pathway

1 reference

12 December 2020

Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases

1 reference

12 December 2020

Inhibitory activity of anti-beta 2-glycoprotein I antibody on factor Va degradation by activated-protein C and its cofactor protein S

1 reference

12 December 2020

On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies

1 reference

12 December 2020

Calibrated automated thrombin generation measurement in clotting plasma

1 reference

12 December 2020

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

12 December 2020

Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.

1 reference

12 December 2020

Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus

1 reference

12 December 2020

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

12 December 2020

Influence of lupus anticoagulant on a commercially available kit for APC-resistance

1 reference

12 December 2020

Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study.

1 reference

12 December 2020

Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism

1 reference

12 December 2020

Pursuing the debate on the serologic criteria that define the antiphospholipid syndrome

1 reference

12 December 2020

Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants

1 reference

12 December 2020

Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin

1 reference

12 December 2020

Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay

1 reference

12 December 2020

Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk

1 reference

12 December 2020

The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies

1 reference

12 December 2020

Phenotyping the haemostatic system by thrombography--potential for the estimation of thrombotic risk.

1 reference

12 December 2020

10.1007/S11926-009-0011-7

Identifiers

DOI

1 reference

20 August 2017

1 reference